Report: FDA looks for more women in medtech trials-massdevice: Nearly half of the premarket approvals and humanitarian device exemptions handed out since 1991 have included post-approval approval requirements, and sex-based data is available for more than 90% of them, according to the study authors. The reports show that women frequently make up less than half of the patients population in cardiovascular, orthopedic, and renal/urologic studies.
